Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNU6-395P is a processed pseudogene related to the U6 small nuclear RNA family[5]. U6 snRNAs are core components of the major spliceosome, which catalyzes pre-mRNA splicing in eukaryotes[1][3]. Pseudogenes such as RNU6-395P arise when an RNA gene is retrotransposed and subsequently loses critical regulatory or coding features, typically rendering them non-functional[2][4]. Recent research shows that a subset of pseudogenes may acquire regulatory functions, including modulation of chromatin, miRNA sponging, or production of non-coding transcripts, but there is no specific evidence that RNU6-395P is functionally expressed or involved in these processes[5]. Expression databases report evidence of transcription in a variety of tissues, but no specific cellular function, disease role, or therapeutic relevance has been established for RNU6-395P[5].
Not applicable; as no drugs are reported to target RNU6-395P.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, U6 small nuclear 395, pseudogene (RNU6-395P).